These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15088913)

  • 21. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relaxant effect of ginseng saponin on the bladder and prostatic urethra: an in vitro and in vivo study.
    Jang HA; Cho S; Kang SG; Ko YH; Kang SH; Bae JH; Cheon J; Kim JJ; Lee JG
    Urol Int; 2012; 88(4):463-9. PubMed ID: 22507987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of age on symptoms and urodynamic- and cystoscopic findings in benign prostatic hypertrophy.
    Simonsen O; Møller-Madsen B; Dørflinger T; Nørgåard JP; Jørgensen HS; Lundhus E
    Urol Res; 1987; 15(6):355-8. PubMed ID: 2448939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction.
    Pyun JH; Kang SG; Kang SH; Cheon J; Kim JJ; Lee JG
    Kaohsiung J Med Sci; 2017 Sep; 33(9):458-463. PubMed ID: 28865604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of Tadenan on bladder function secondary to partial outlet obstruction.
    Levin RM; Riffaud JP; Bellamy F; Rohrmann D; Habib M; Krasnopolsky L; Zhao Y; Wein AJ
    J Urol; 1996 Apr; 155(4):1466-70. PubMed ID: 8632612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
    Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of pressure-flow parameters.
    Eri LM; Wessel N; Tysland O; Berge V
    Neurourol Urodyn; 2002; 21(3):186-93. PubMed ID: 11948710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
    Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
    J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 36. Uroflowmetry and urodynamics.
    Kaplan SA; Te AE
    Urol Clin North Am; 1995 May; 22(2):309-20. PubMed ID: 7539177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urodynamic results of laser treatment in patients with benign prostatic hyperplasia. Can outlet obstruction be relieved?
    de Wildt MJ; Te Slaa E; Rosier PF; Wijkstra H; Debruyne FM; de la Rosette JJ
    J Urol; 1995 Jul; 154(1):174-80. PubMed ID: 7539860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].
    de la Taille A; Robert G; Descazeaud A
    Prog Urol; 2018 Nov; 28(15):813-820. PubMed ID: 30262261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of tamsulosin hydrochloride on bladder outlet obstruction associated with benign prostatic hyperplasia: effect on urethral pressure profile and cystometrogram].
    Murayama K; Katsumi T; Tajika E; Kawaguchi K; Ueki O
    Hinyokika Kiyo; 1997 Nov; 43(11):799-803. PubMed ID: 9436025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perugia urodynamic method of analysis (PUMA): a new advanced method of urodynamic analysis applied clinically and compared with other advanced methods.
    Porena M; Biscotto S; Costantini E; Mearini E; Verdini L
    Neurourol Urodyn; 2003; 22(3):206-22. PubMed ID: 12707871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.